68 Ga-DOTANOC: biodistribution and dosimetry in patients affected by neuroendocrine tumors C Pettinato, A Sarnelli, M Di Donna, S Civollani, C Nanni, G Montini, ... European journal of nuclear medicine and molecular imaging 35 (1), 72-79, 2008 | 182 | 2008 |
Treatment with the Radiolabelled Somatostatin Analog 177Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors M Sansovini, S Severi, A Ambrosetti, M Monti, O Nanni, A Sarnelli, ... Neuroendocrinology 97 (4), 347-354, 2013 | 132 | 2013 |
Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning M Cremonesi, ME Ferrari, L Bodei, C Chiesa, A Sarnelli, C Garibaldi, ... European journal of nuclear medicine and molecular imaging 45, 2426-2441, 2018 | 118 | 2018 |
Kidney Dosimetry in 177Lu and 90Y Peptide Receptor Radionuclide Therapy: Influence of Image Timing, Time-Activity Integration Method, and Risk Factors F Guerriero, ME Ferrari, F Botta, F Fioroni, E Grassi, A Versari, A Sarnelli, ... BioMed research international 2013, 2013 | 105 | 2013 |
Peptide receptor radionuclide therapy with 177Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and 18F-FDG PET A Ianniello, M Sansovini, S Severi, S Nicolini, CM Grana, K Massri, ... European journal of nuclear medicine and molecular imaging 43, 1040-1046, 2016 | 102 | 2016 |
68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients P Caroli, I Sandler, F Matteucci, U De Giorgi, L Uccelli, M Celli, F Foca, ... European journal of nuclear medicine and molecular imaging 45, 2035-2044, 2018 | 88 | 2018 |
Evaluation of the minimum iodine concentration for contrast-enhanced subtraction mammography P Baldelli, A Bravin, C Di Maggio, G Gennaro, A Sarnelli, A Taibi, ... Physics in Medicine & Biology 51 (17), 4233, 2006 | 70 | 2006 |
K-edge digital subtraction imaging based on a dichromatic and compact x-ray source A Sarnelli, A Taibi, A Tuffanelli, G Baldazzi, D Bollini, AEC Rodriguez, ... Physics in Medicine & Biology 49 (14), 3291, 2004 | 54 | 2004 |
Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians G Storci, S De Carolis, A Papi, MG Bacalini, N Gensous, E Marasco, ... Cell Death & Differentiation 26 (9), 1845-1858, 2019 | 45 | 2019 |
Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer … G Paganelli, A Sarnelli, S Severi, M Sansovini, ML Belli, M Monti, F Foca, ... European Journal of Nuclear Medicine and Molecular Imaging 47, 3008-3017, 2020 | 40 | 2020 |
In vitro irradiation system for radiobiological experiments A Tesei, A Sarnelli, C Arienti, E Menghi, L Medri, E Gabucci, S Pignatta, ... Radiation Oncology 8, 1-12, 2013 | 39 | 2013 |
Initial safety and tumor control results from a “First-in-Human” multicenter prospective trial evaluating a novel alpha-emitting radionuclide for the treatment of locally … A Popovtzer, E Rosenfeld, A Mizrachi, SR Bellia, R Ben-Hur, G Feliciani, ... International Journal of Radiation Oncology* Biology* Physics 106 (3), 571-578, 2020 | 37 | 2020 |
K-edge digital subtraction imaging with dichromatic x-ray sources: SNR and dose studies A Sarnelli, H Elleaume, A Taibi, M Gambaccini, A Bravin Physics in Medicine & Biology 51 (17), 4311, 2006 | 37 | 2006 |
Dosimetry of 177Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol A Sarnelli, ML Belli, V Di Iorio, E Mezzenga, M Celli, S Severi, E Tardelli, ... Molecules 24 (3), 621, 2019 | 36 | 2019 |
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors S Nicolini, L Bodei, A Bongiovanni, M Sansovini, I Grassi, T Ibrahim, ... European journal of nuclear medicine and molecular imaging, 1-8, 2021 | 35 | 2021 |
A novel benchmarking approach to assess the agreement among radiomic tools A Bettinelli, F Marturano, M Avanzo, E Loi, E Menghi, E Mezzenga, ... Radiology 303 (3), 533-541, 2022 | 34 | 2022 |
Quantitative accuracy of 177Lu SPECT imaging for molecular radiotherapy E Mezzenga, V D’Errico, M D’Arienzo, L Strigari, K Panagiota, F Matteucci, ... PLoS One 12 (8), e0182888, 2017 | 31 | 2017 |
Reduction of 68Ga-PSMA renal uptake with mannitol infusion: preliminary results F Matteucci, E Mezzenga, P Caroli, V Di Iorio, A Sarnelli, M Celli, L Fantini, ... European journal of nuclear medicine and molecular imaging 44, 2189-2194, 2017 | 30 | 2017 |
Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma M Zanoni, AC Sarti, A Zamagni, M Cortesi, S Pignatta, C Arienti, M Tebaldi, ... Cell Death & Disease 13 (1), 80, 2022 | 29 | 2022 |
Clinical evidence of abscopal effect in cutaneous squamous cell carcinoma treated with diffusing alpha emitters radiation therapy: a case report S Bellia, G Feliciani, M Duca, M Monti, V Turri, A Sarnelli, A Romeo, ... Journal of Contemporary Brachytherapy 11 (5), 449-457, 2019 | 28 | 2019 |